ATE457160T1 - Vanillin-polymere zwecks verwendung zur verdunklung der haut - Google Patents

Vanillin-polymere zwecks verwendung zur verdunklung der haut

Info

Publication number
ATE457160T1
ATE457160T1 AT04813962T AT04813962T ATE457160T1 AT E457160 T1 ATE457160 T1 AT E457160T1 AT 04813962 T AT04813962 T AT 04813962T AT 04813962 T AT04813962 T AT 04813962T AT E457160 T1 ATE457160 T1 AT E457160T1
Authority
AT
Austria
Prior art keywords
skin
darken
vanillin
polymers
vanillin polymers
Prior art date
Application number
AT04813962T
Other languages
English (en)
Inventor
Connie Baozhen Lin
Original Assignee
Johnson & Johnson Consumer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer filed Critical Johnson & Johnson Consumer
Application granted granted Critical
Publication of ATE457160T1 publication Critical patent/ATE457160T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
AT04813962T 2003-12-12 2004-12-09 Vanillin-polymere zwecks verwendung zur verdunklung der haut ATE457160T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/735,540 US7935331B2 (en) 2003-12-12 2003-12-12 Vanillin polymers for use in darkening the skin
PCT/US2004/041716 WO2005058262A1 (en) 2003-12-12 2004-12-09 Vanillin polymers for use in darkening the skin

Publications (1)

Publication Number Publication Date
ATE457160T1 true ATE457160T1 (de) 2010-02-15

Family

ID=34653644

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04813962T ATE457160T1 (de) 2003-12-12 2004-12-09 Vanillin-polymere zwecks verwendung zur verdunklung der haut

Country Status (6)

Country Link
US (1) US7935331B2 (de)
EP (1) EP1701689B1 (de)
AT (1) ATE457160T1 (de)
CA (1) CA2547762C (de)
DE (1) DE602004025507D1 (de)
WO (1) WO2005058262A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8278359B2 (en) 2005-02-25 2012-10-02 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof to treat acne or reduce the appearance of oil or pores on the skin
EP2011471A1 (de) * 2007-07-02 2009-01-07 Johnson & Johnson Consumer France SAS Schäumende Ölzubereitungen
WO2009005151A1 (ja) * 2007-07-05 2009-01-08 Nissan Chemical Industries, Ltd. 新規脂質ペプチド並びにヒドロゲル
US20090087395A1 (en) 2007-10-01 2009-04-02 Lin Connie B Compositions for use in darkening the skin
US8481006B2 (en) * 2008-04-25 2013-07-09 New Sunshine, Llc Melt formula
IT1394672B1 (it) * 2009-02-11 2012-07-13 Wellpharma S R L Preparazione topica
EP2494953B1 (de) * 2009-10-26 2017-09-27 Nissan Chemical Industries, Ltd. Zusammensetzung zur verwendung als kosmetikpräparat oder externes hautpräparat
US9475709B2 (en) 2010-08-25 2016-10-25 Lockheed Martin Corporation Perforated graphene deionization or desalination
EP2618802A1 (de) * 2010-09-22 2013-07-31 L'Oréal Kosmetisches behandlungsverfahren mit orthodiphenolderivaten, neue verbindungen und kosmetische zusammensetzung damit
KR101769456B1 (ko) 2011-05-26 2017-08-30 주식회사 엘지생활건강 유통기한의 경과에 대한 표시 기능을 가진 화장료 조성물
US9834809B2 (en) 2014-02-28 2017-12-05 Lockheed Martin Corporation Syringe for obtaining nano-sized materials for selective assays and related methods of use
US10653824B2 (en) 2012-05-25 2020-05-19 Lockheed Martin Corporation Two-dimensional materials and uses thereof
US9610546B2 (en) 2014-03-12 2017-04-04 Lockheed Martin Corporation Separation membranes formed from perforated graphene and methods for use thereof
US10376845B2 (en) 2016-04-14 2019-08-13 Lockheed Martin Corporation Membranes with tunable selectivity
US10418143B2 (en) 2015-08-05 2019-09-17 Lockheed Martin Corporation Perforatable sheets of graphene-based material
US9744617B2 (en) 2014-01-31 2017-08-29 Lockheed Martin Corporation Methods for perforating multi-layer graphene through ion bombardment
US10980919B2 (en) 2016-04-14 2021-04-20 Lockheed Martin Corporation Methods for in vivo and in vitro use of graphene and other two-dimensional materials
WO2014164621A1 (en) 2013-03-12 2014-10-09 Lockheed Martin Corporation Method for forming filter with uniform aperture size
US9572918B2 (en) 2013-06-21 2017-02-21 Lockheed Martin Corporation Graphene-based filter for isolating a substance from blood
CA2938305A1 (en) 2014-01-31 2015-08-06 Lockheed Martin Corporation Processes for forming composite structures with a two-dimensional material using a porous, non-sacrificial supporting layer
CN105940479A (zh) 2014-01-31 2016-09-14 洛克希德马丁公司 使用宽离子场穿孔二维材料
CA2942496A1 (en) 2014-03-12 2015-09-17 Lockheed Martin Corporation Separation membranes formed from perforated graphene
EA201790508A1 (ru) 2014-09-02 2017-08-31 Локхид Мартин Корпорейшн Мембраны гемодиализа и гемофильтрации на основе двумерного мембранного материала и способы их применения
JP2018530499A (ja) 2015-08-06 2018-10-18 ロッキード・マーチン・コーポレーション グラフェンのナノ粒子変性及び穿孔
WO2017180139A1 (en) 2016-04-14 2017-10-19 Lockheed Martin Corporation Two-dimensional membrane structures having flow passages
JP2019511451A (ja) 2016-04-14 2019-04-25 ロッキード・マーチン・コーポレーション 浮遊法を用いてグラフェンシートを大判転写用に処理する方法
SG11201808961QA (en) 2016-04-14 2018-11-29 Lockheed Corp Methods for in situ monitoring and control of defect formation or healing
WO2017180141A1 (en) 2016-04-14 2017-10-19 Lockheed Martin Corporation Selective interfacial mitigation of graphene defects
KR102260329B1 (ko) * 2019-08-05 2021-06-02 주식회사 엘지생활건강 발수 및 발유 특성이 동시에 우수한 고분자 피막제 및 이를 포함하는 화장 지속성이 우수한 화장료 조성물

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2553146A (en) 1946-09-13 1951-05-15 Sulphite Products Corp Production of vanillic acid
US4230817A (en) * 1979-03-02 1980-10-28 Celanese Corporation Thermotropic polyesters derived from ferulic acid and a process for preparing the polyesters
US4690825A (en) * 1985-10-04 1987-09-01 Advanced Polymer Systems, Inc. Method for delivering an active ingredient by controlled time release utilizing a novel delivery vehicle which can be prepared by a process utilizing the active ingredient as a porogen
US5145675A (en) * 1986-03-31 1992-09-08 Advanced Polymer Systems, Inc. Two step method for preparation of controlled release formulations
US4714609A (en) * 1986-07-21 1987-12-22 Laverne Stanley Skin tanning composition
US5013497A (en) * 1988-03-03 1991-05-07 Micro-Pak, Inc. Method and apparatus for producing lipid vesicles
US5227459A (en) * 1990-05-18 1993-07-13 Yale University Synthetic melanin
US5216116A (en) * 1990-05-18 1993-06-01 Yale University Soluble melanin
US5225435A (en) * 1990-05-18 1993-07-06 Yale University Soluble melanin
US5218079A (en) * 1990-05-18 1993-06-08 Yale University Soluble melanin
US5260055A (en) * 1991-02-19 1993-11-09 John Imperante Fatty carboxylic silicone amine salts
US5260065A (en) 1991-09-17 1993-11-09 Micro Vesicular Systems, Inc. Blended lipid vesicles
US5247055A (en) 1992-03-20 1993-09-21 Stenger Smith John D Accordion-like polymers for nonlinear applications
US5744125A (en) * 1993-08-19 1998-04-28 Yale University Cosmetic melanins
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents

Also Published As

Publication number Publication date
CA2547762A1 (en) 2005-06-30
US7935331B2 (en) 2011-05-03
WO2005058262A1 (en) 2005-06-30
EP1701689B1 (de) 2010-02-10
EP1701689A1 (de) 2006-09-20
DE602004025507D1 (de) 2010-03-25
CA2547762C (en) 2012-06-19
US20050129633A1 (en) 2005-06-16

Similar Documents

Publication Publication Date Title
ATE457160T1 (de) Vanillin-polymere zwecks verwendung zur verdunklung der haut
ATE477249T1 (de) Heteroarylbenzamidderivate zur verwendung als glk-aktivatoren bei der behandlung von diabetes
DE602004021585D1 (de) 5,7-DIAMINOPYRAZOLOi4,3-D PYRIMIDINE ZUR VERWENDUNG IN DER BEHANDLUNG VON BLUTHOCHDRUCK
DE60235866D1 (de) Verwendung von speziellen Aminosilikonen zur Nachbehandlung in der direkten oder oxidativen Färbung von Keratinfasern
DE60314865D1 (de) Verfahren zur herstellung von modifiziertem polymer, danach erhaltenes modifiziertes polymer und kautschukzusammensetzung
DE602004010791D1 (de) 2,5-substituiertetetrahydroisochinoline zur verwendung als 5-ht6 modulatoren
ATE480383T1 (de) Zusammensetzungen und verfahren zur verbesserung der aufwärmrate von pet unter verwendung von aktivkohle
ATE402987T1 (de) Klebestruktur zur befestigung auf der haut
DE602006018936D1 (de) Flüssigkeit enthaltend trehalose zur verwendung bei der prävention von gewebeadhäsion
DE502005009861D1 (de) 5,6-dialkyl-7-amino-triazolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel
DE602005019082D1 (de) Biomedizinische artikel mit amphiphilen blockcopolymeren
ATE451402T1 (de) Methacrylatharze zur herstellung von fahrbahnmarkierungen
CY1112590T1 (el) 3-[4-(ΔΙΒΕΝΖΟ[b,f][1,4]ΟΞΑΖΕΠΙΝ-11-ΥΛΟ)-ΠΙΠΕΡΑΖΙΝ-1-ΥΛΟ]-2,2-ΔΙΜΕΘΥΛΟ ΠΡΟΠΑΝΟΪΚΟ ΟΞΥ ΓΙΑ ΧΡΗΣΗ ΣΤΗΝ ΑΝΤΙΜΕΤΩΠΙΣΗ ΔΙΑΤΑΡΑΧΩΝ ΤΟΥ ΥΠΝΟΥ
DE602006010400D1 (de) Olanzapin-analoga und verfahren zu ihrer verwendung
DE602006017367D1 (de) Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut
DE602005007220D1 (de) Tetrahydropyridothiophenen zur verwendung in der behandlung von krebs
DE60318744D1 (de) ZUSAMMENSETZUNG AUF BASIS VON 2-CYANOACRYLAT, VERFAHREN UND MITTEL ZUR EVALUIERUNG DER HuRTUNG DAVON
DE502004011765D1 (de) Implantat zur Spreizung der Nasenflügel
DE602006021626D1 (de) 1,1-dioxo-thiomorpholinyl-indolyl-methanon-derivate zur verwendung als h3-modulatoren
DE602006009901D1 (de) Verfahren zur herstellung von 7-ethyl-10-hydroxycamptothecin
DE602004000952D1 (de) Reibungsmaterialzusammensetzung und Reibungsmaterial unter Verwendung derselben
DE60329469D1 (de) Herzschrittmacher mit anpassbaren zeitfenstern zur detektion von arrhythmie
ATE372150T1 (de) Verwendung von speziellen polyolen zur kristallisationsinhibierung von oniumaldehyden bzw. -ketonen
ATE533517T1 (de) Biologisch abbaubare polyphosphazene mit pyrrolidonseitengruppen
DE60325194D1 (de) Methoden zur verwendung von lamellaren körpern für therapeutische zwecke

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties